Tag: AI in GxP Environment
26 Aug 2026
Understand How FDA and EMA View AI Systems in Regulated GxP Use Cases
Overview The FDA and EMA have been developing their approaches to AI in GxP environments through guidance documents, regulatory actions, and collaborative […]
Read More
26 Aug 2026
Cybersecurity: Why Training Is the #1 Security Measure in Life Sciences and Pharmaceuticals
Overview In the pharmaceutical and life sciences industry, cybersecurity has become a critical concern as organizations increasingly adopt AI and […]
Read More
26 Aug 2026
Regulatory Landscape for AI in GxP (FDA, EMA)
Overview The regulatory landscape for AI in GxP environments is rapidly evolving as regulatory bodies develop frameworks to ensure the safe and […]
Read More
26 Aug 2026
AI in an GxP Environment – Online Training (2026)
Overview Artificial Intelligence and Machine Learning are rapidly transforming pharmaceutical manufacturing, quality control, and decision-making processes. However, the unique characteristics […]
Read More